{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:55:21Z","timestamp":1791474921306,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvsvenous.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jvsv.2026.102557","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T06:16:04Z","timestamp":1781936164000},"page":"102557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glucagon-like peptide-1 receptor agonists are associated with fewer venous thromboembolic events and limb complications in obese patients with chronic venous insufficiency"],"prefix":"10.1016","volume":"14","author":[{"given":"Lavender","family":"Micalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Archie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent L.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adedunmola P.","family":"Adewale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan Vu","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8419-1630","authenticated-orcid":false,"given":"Juan Carlos","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvsv.2026.102557_bib1","article-title":"Increased risk of deep vein thrombosis, pulmonary embolism, and all-cause mortality in chronic venous disorder: a large-scale retrospective cohort study","volume":"12","author":"Moderegger","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jvsv.2026.102557_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/20503121221118992","article-title":"Global impact and contributing factors in varicose vein disease development","volume":"10","author":"Aslam","year":"2022","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.jvsv.2026.102557_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.semvascsurg.2021.02.007","article-title":"Defining the human and health care costs of chronic venous insufficiency","volume":"34","author":"Kim","year":"2021","journal-title":"Semin Vasc Surg"},{"key":"10.1016\/j.jvsv.2026.102557_bib4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.2018.0246","article-title":"Association of varicose veins with incident venous thromboembolism and peripheral artery disease","volume":"319","author":"Chang","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jvsv.2026.102557_bib5","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(25)02105-1","article-title":"Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits","volume":"407","author":"Nauck","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.jvsv.2026.102557_bib6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.117.028136","article-title":"Cardiovascular actions and clinical outcomes with glucagon-like Peptide-1 receptor agonists and dipeptidyl Peptidase-4 inhibitors","volume":"136","author":"Nauck","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvsv.2026.102557_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/mr-2024-0011","article-title":"Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism","volume":"4","author":"Hoffman","year":"2024","journal-title":"Med Rev (2021)"},{"key":"10.1016\/j.jvsv.2026.102557_bib8","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/bloodadvances.2025015871","article-title":"Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulation","volume":"9","author":"Chiang","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jvsv.2026.102557_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.039446","article-title":"Glucagon-like peptide-1 receptor agonists and risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Liu","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jvsv.2026.102557_bib10","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1056\/NEJMcp2310224","article-title":"Nonsurgical management of chronic venous insufficiency","volume":"391","author":"Fukaya","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvsv.2026.102557_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110292","article-title":"The interplay between obesity and venous thromboembolism: from molecular aspects to clinical issue","volume":"26","author":"Zawadzka","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jvsv.2026.102557_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/00368504251409997","article-title":"Obesity as a modifiable determinant of chronic venous disease prevalence: insights from a cross-sectional study in Brazilian patients at a university hospital","volume":"108","author":"Senfft","year":"2025","journal-title":"Sci Prog"},{"key":"10.1016\/j.jvsv.2026.102557_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejvs.2012.12.011","article-title":"Body mass index and primary chronic venous disease--a cross-sectional study","volume":"45","author":"Vlajinac","year":"2013","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvsv.2026.102557_bib14","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jvs.2010.04.023","article-title":"Impact of obesity on venous hemodynamics of the lower limbs","volume":"52","author":"Willenberg","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvsv.2026.102557_bib15","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2014.04.049","article-title":"Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular surgery\u00ae and the American Venous Forum","volume":"60","author":"O\u2019Donnell","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvsv.2026.102557_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.suc.2017.11.002","article-title":"Pathophysiology of chronic venous disease and venous ulcers","volume":"98","author":"Raffetto","year":"2018","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.jvsv.2026.102557_bib17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.115.227330","article-title":"Matrix metalloproteinases as regulators of vein structure and function: implications in chronic venous disease","volume":"355","author":"MacColl","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jvsv.2026.102557_bib18","article-title":"Impact of GLP-1 receptor agonists on healing outcomes in diabetic patients with chronic venous ulcers","volume":"14","author":"Narvaez","year":"2026","journal-title":"J Vasc Surg Venous Lymphatic Disord"},{"key":"10.1016\/j.jvsv.2026.102557_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2025.03.034","article-title":"GLP-1 receptor agonists are associated with fewer major complications, hospital admissions, and better venous ulcer healing","volume":"81","author":"Go","year":"2025","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvsv.2026.102557_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1754925","article-title":"Potential application of mono-, dual-, and triple-target GLP-1 receptor agonists in improving the prognosis of patients with diabetic foot ulcers","volume":"16","author":"Li","year":"2026","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jvsv.2026.102557_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026586","article-title":"Liraglutide accelerates ischemia-induced angiogenesis in a murine diabetic model","volume":"12","author":"Zhu","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jvsv.2026.102557_bib22","article-title":"Glucagon-like peptide-1 receptor agonists and the endothelium: molecular and clinical insights into cardiovascular protection","volume":"12","author":"Battistoni","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jvsv.2026.102557_bib23","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.2337\/dc12-2469","article-title":"Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes","volume":"36","author":"Ceriello","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jvsv.2026.102557_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/atv.0000615456.97862.30","article-title":"Endothelial GLP-1 (glucagon-like peptide-1) receptor mediates cardiovascular protection by liraglutide in mice with experimental arterial hypertension","volume":"40","author":"Helmstadter","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvsv.2026.102557_bib25","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.jvs.2026.02.003","article-title":"Glucagon-like peptide-1 receptor agonist therapy is associated with improved outcomes of arteriovenous fistulae","volume":"83","author":"Hsu","year":"2026","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvsv.2026.102557_bib26","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.jacc.2025.08.027","article-title":"Cardiovascular effects and tolerability of GLP-1 receptor agonists","volume":"86","author":"Galli","year":"2025","journal-title":"JACC"},{"key":"10.1016\/j.jvsv.2026.102557_bib27","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/dom.70391","article-title":"Impact of glucagon-like peptide-1 receptor agonism-based therapies on limb outcomes in peripheral artery disease and type 2 diabetes: an updated systematic review and meta-analysis","volume":"28","author":"Dutta","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jvsv.2026.102557_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.amjcard.2022.02.013","article-title":"Correlates of glucagon-like peptide-1 receptor agonist use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus (from the Department of Veterans Affairs)","volume":"172","author":"Al Rifai","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvsv.2026.102557_bib29","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvsv.2026.102557_bib30","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/S0140-6736(25)01375-3","article-title":"Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial","volume":"406","author":"Deanfield","year":"2025","journal-title":"Lancet"}],"container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X26001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X26001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:35:29Z","timestamp":1786750529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213333X26001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2213333X26001174"],"URL":"https:\/\/doi.org\/10.1016\/j.jvsv.2026.102557","relation":{},"ISSN":["2213-333X"],"issn-type":[{"value":"2213-333X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 receptor agonists are associated with fewer venous thromboembolic events and limb complications in obese patients with chronic venous insufficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery: Venous and Lymphatic Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvsv.2026.102557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}],"article-number":"102557"}}